| Clu |
gene |
4 |
2 |
apolipoprotein J, clusterin |
| Cluster 1 |
cohort |
3 |
2 |
|
| c-myc |
gene |
6 |
4 |
MYC |
| Cnih3 |
gene |
4 |
3 |
CNIH-3, Cnih3, Cornichon homolog 3, cornichon family AMPA receptor auxiliary protein 3, cornichon-3 |
| CNP |
variant |
5 |
3 |
CNPs, common copy number polymorphism, common copy number polymorphisms, copy number polymorphism, diallelic copy number polymorphism, human copy number variation |
| CNQX |
drug |
8 |
7 |
6-Cyano-7-nitroquinoxaline-2,3-dione, 6-cyano-7-nitroquinoxaline-2,3-dione, AMPA receptor blocker CNQX, AMPA/kainate receptor antagonist CNQX, CNQX (antagonist of AMPA receptors), competitive AMPA receptor antagonist |
| Cnr1 |
gene |
21 |
— |
CB1, CB1 receptor, CB1 receptors, CB1R, CB1Rs, Cannabinoid receptor 1, Cannabinoid receptor-1, Cnr1, cannabinoid 1 receptor, cannabinoid receptor 1, cannabinoid receptor 1 gene, cannabinoid receptor gene, cannabinoid receptor type 1, cannabinoid-1 receptor, type-1 cannabinoid receptor |
| CNR2 |
gene |
3 |
— |
CB2, cannabinoid receptors |
| CNS disinhibition |
phenotype |
4 |
4 |
CNS disinhibition, central nervous system disinhibition, hyperexcitability |
| CNS dysfunction |
phenotype |
5 |
2 |
central nervous system dysfunction |
| CNS hyperexcitability |
phenotype |
5 |
4 |
neuronal hyperexcitability |
| CNTF |
drug |
2 |
— |
ciliary neurotrophic factor |
| CNTNAP2 |
gene |
5 |
5 |
Cntnap2, Contactin-associated protein 2, contactin associated protein-like 2, contactin-associated protein-like 2 |
| CNV |
variant |
29 |
20 |
CNV allele, CNV loci, CNV region, CNV regions, CNV studies, CNV-related genomic disorder, CNVs, CNVs >10 Kb, Copy Number Variation, Copy number variation, copy number variant, copy number variation, copy-number variant, de novo CNV, de novo CNV events, deletions, duplications, insertions, large CNV, non-rare CNV, novel CNV, putative de novo CNV, rare CNV, recurrent CNV, spontaneous CNV, structural variant, very rare CNV |
| CNVs |
variant |
10 |
5 |
CNV, CNVs, Copy Number Variation, copy number variants, copy number variations |
| CO2 |
drug |
10 |
6 |
CO2 inhalation, carbon dioxide |
| cocaine |
phenotype |
130 |
88 |
CA, CD, CD-phenotype, COC, CoD, DSM dependence on cocaine, DSM-IV cocaine dependence, DSM‑IV CoD, addiction, addiction to cocaine, benzoylmethyl ecgonine, chronic cocaine, chronic cocaine use, cocaine, cocaine abuse, cocaine abuse/dependence diagnosis, cocaine abusers, cocaine addicted individuals, cocaine addiction, cocaine addicts, cocaine dependence, cocaine dependence severity, cocaine dependence symptoms, cocaine dependence treatment, cocaine dependent, cocaine dependent adults, cocaine dependent individuals, cocaine dependent patients, cocaine dependent persons, cocaine dependent subjects, cocaine exposure, cocaine group, cocaine reward, cocaine use, cocaine use disorder, cocaine users, cocaine-addicted, cocaine-addicted individuals, cocaine-addicted subjects, cocaine-dependent, cocaine-dependent individuals, cocaine-dependent patients, cocaine‑addicted, cocaine‑addicted brain, coke, dependence symptoms, indices of cocaine dependence severity, intravenous cocaine, powder cocaine, prenatal cocaine exposure, rewarding effects of cocaine, severity of cocaine dependence, smoked cocaine base, vulnerability to cocaine abuse |
| cocaine group |
cohort |
2 |
1 |
cocaine subjects |
| cocaine-induced paranoia |
phenotype |
3 |
3 |
CIP |
| cocaine self-administration |
phenotype |
12 |
6 |
cocaine SA |
